The initial reporter received questionable elecsys ft3 iii results for one patient tested on a cobas 8000 e 602 module.The customer reported out the results to a physician who asked for re-measurement of the sample.Due to the patient's ft3 result not matching the patient's previous ft3 result, the customer performed repeat testing on three cobas 8000 e 801 modules and sent the sample for investigation.During the investigation, the patient's sample was tested on a cobas 8000 e 801 module, a cobas e 411 immunoassay analyzer, and a siemens centaur analyzer.The serial numbers of the customer's e 602 module and e 801 modules were requested but not provided.
|
During the investigation, the patient's sample was tested on a cobas 8000 e 602 module, a cobas e 411 immunoassay analyzer, and a siemens centaur analyzer.The customer's calibration and qc data were requested but not provided.The patient's sample was requested for an investigation of interfering factors, but the sample was not available.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.".The investigation did not identify a product problem.The cause of the event could not be determined.
|